Piramal Pharma Limited Announces Consolidated Results for Q3 and 9M FY2024

Contributed by: PR Newswire

Images

PR Newswire associated0

Tags

Piramal

More Like This

PR Newswire associated0

Piramal Pharma Limited Announces Consolidated Results for Q1FY25

PR Newswire associated0

Piramal Pharma Limited Announces Results for Q4 and FY2024

PR Newswire associated0

Piramal Pharma Limited Announces Consolidated Results for Q2 and H1 FY2024

PR Newswire associated0

Piramal Pharma Limited Announces Results for Q2 and H1 FY25

PR Newswire associated0

Piramal Pharma releases its Sustainability Report for FY 2023-24 under the theme, 'Building Resilience for a Sustainable Tomorrow'

PR Newswire associated0

Piramal Pharma Solutions Achieves Revenue Threshold on Innovation Work

PR Newswire associated0

Piramal Pharma's GHG Commitment Validated and Approved by SBTi

PR Newswire associated0

Piramal Pharma Solutions Announces $80M Expansion Plan for Sterile Injectables Facility in Lexington, Kentucky